Most inborn errors of immunity (IEIs) are caused by defects that arise somewhere along the developmental path between hematopoietic stem cells (HSCs) and mature immune cells. Replacement of mutant ...

A research team led by associate professors Yohei Funakoshi and Kimikazu Yakushijin and Professor Hironobu Minami of the ...

A real-world study of fifty multiple myeloma patients found that high-dose melphalan with autologous stem cell ...

For people living with multiple sclerosis (MS), the search for effective treatment options can feel like a never-ending journey. While disease-modifying therapies (DMTs) have improved outcomes for ...

The pGen-SHM plot combines BCR generation probability and somatic hypermutation to track humoral immune recovery after stem cell transplantation. The approach has revealed distinct maturation patterns ...

University of Zurich researchers found that a one-hour treatment with activated protein C keeps human blood stem cells in a ...

IntroductionThis year marks 22 years since I was diagnosed with myelofibrosis in 2004.I underwent a hematopoietic stem cell ...

Blood cancer patients who may have previously struggled to find a donor for transplantation now have more options. A new study shows that patients achieve good outcomes with a partial match drawn from ...

Researchers demonstrated that haplo-HSCT, combined with post-transplant cyclophosphamide, is a feasible and effective treatment for hematologic malignancies even in resource-limited settings.

The hematopoietic stem cell transplantation market is experiencing steady growth, driven by the rising prevalence of hematologic malignancies, advances in transplant techniques, donor matching ...